Complement factor H (FH) is a major regulator of the complement alternative pathway, its mutations predispose to an uncontrolled activation in the kidney and on blood cells and to secondary C3 deficiency. The gene discussed is FH; the disease is hyperinsulinemic hypoglycemia, familial, 4.